Some level of tumor microenvironment characterization can often be achieved by genome and transcriptome-based technologies (including granzyme b/IFNg), flow cytometry and simple tumor cell killing assays [17,39] but these are not cell specific. This evidence concerns the gene GZMB and neoplasm.